Treating spondyloarthritis early: does it matter? Results from a systematic literature review.

Dafne CapelusnikDiego BenaventDésirée van der HeijdeRobert LandewéDenis PoddubnyyAstrid van TubergenLouise FalzonVictoria Navarro-CompánSofia Ramiro

Published in: Rheumatology (Oxford, England) (2022)

Evidence towards better outcomes in early axSpA is very limited and restricted to nr-axSpA and <5 years symptom duration. When early axSpA is defined based on disease duration or radiographic damage, no differences in response to treatment are found.

Keyphrases

oxidative stress
ankylosing spondylitis
skeletal muscle
systemic lupus erythematosus
insulin resistance
smoking cessation
weight loss